Reports: Walmart Wants to Buy PillPack, as Healthcare Ambitions Grow
from Xconomy by Jeff Engel Walmart is reportedly talking with PillPack about acquiring the online pharmacy and medication management company, a deal that would strengthen the retail giant’s healthcare offerings and potentially help it fend off Amazon if the Seattle e-commerce company starts selling prescription drugs. The PillPack acquisition talks ...
Monitor detects dangerously low white blood cell levels
from MIT News by Anne Trafton One of the major side effects of chemotherapy is a sharp drop in white blood cells, which leaves patients vulnerable to dangerous infections. MIT researchers have now developed a portable device that could be used to monitor patients’ white blood cell levels at home, without taking ...
One MIT Adtech Startup is Generating Traffic Data to Help Build ‘Smarter’ Cities
from Forbes by Frederick Daso Unfortunately, traffic is a necessary part of modern life in a big city. The transportation-consulting firm INRIX found that worldwide traffic congestion cost $305 billion in 2017 in the U.S. An adtech startup is working on a solution to share traffic data with city officials to help ...
What Your Struggling Business Model Can Learn From the Man of Steel
from MIT Sloan News by Meredith Somers Superman stands for truth, justice, and the “American way,” but that credo is also a great example of brand values — a necessary part of a company’s innovation strategy. Even if your company is based on a new “disruptive” business model, you have ...
Former Math Olympiad medalist embraces social entrepreneurship
from MIT News by Fatima Hussain When Mehmet Efe Akengin first entered MIT, he intended to continue his internationally acclaimed mathematics career. The native of Istanbul, Turkey, was one of the country’s youngest gold medalists in the International Mathematical Olympiad (IMO), an annual mathematics competition for high school students. With ...
twoXAR Announces Series A in Quest to Collapse Drug Discovery Timelines
from MIT Sloan News by Edward Mason The pharmaceutical industry’s traditional plodding path for discovering drugs can cost billions of dollars, require more than a dozen years from concept to consumer, and in the end result in a product with a jaw-dropping price tag. Enter twoXAR, a Palo Alto, California, startup ...
Follow